Improved graft survival in cadaveric renal retransplantation by flow crossmatching

Archives of Surgery

Volumn 131, Issue 6, 1996, Pages 599-603

  Nelson, Paul W ^a,e,g   Eschliman, Patty ^a   Shield, Charles F ^b   Aeder, Mark I ^c   Luger, Alan M ^d   Pierce, George E ^f   Bryan, Christopher F ^a  

^a Midwest Organ Bank Inc   (United States)

^b St Francis Medical Center   (United States)

^c Research Medical Center Brookside Campus   (United States)

^d University of Missouri   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^g Midwest Transplant Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G ANTIBODY;

ARTICLE; CADAVER KIDNEY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; REOPERATION; T LYMPHOCYTE;

EID: 0029948707     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430180025004     Document Type: Article

References (14)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N. Engl J Med. 1969;280:735-739.
2. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation. 1992;54:389-394.
3. Fuller TC, Phelan D, Gebel HM, Rodey GE. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation. 1982;34:24-29.
4. Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analysis: a high technology crossmatch technique facilitation transplantation. Transplant Proc. 1983;15:1939.
5. Lee PP, Garovoy MR. Flow cytometry crossmatching: the first 10 years. Transplantation Rev. 1994;8:1-14.
6. Scornik JC. Detection of alloantibodies by flow cytometry: relevance to clinical transplantation. Cytometry. 1995;22:259-263.
7. Cook DJ, Terasaki PI, Iwaki T, Terashita GY, Lau M. An approach to reducing early kidney transplant failure by flow cytometry crossmatching. Clin Transplant. 1987;1:253-256.
8. Lazda VA, Pollak R, Mozes MF, Jonasson O. The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients. Transplantation. 1988;45:562-565.
9. Mahoney RJ, Ault KA, Given SR, et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation. 1990;49:527-535.
10. Talbot D, Cavanagh G, Coates E, et al. Improved graft outcome and reduced complications due to flow cytometric crossmatching and DR matching in renal transplantation. Transplantation. 1992;53:925-928.
11. Berteli AJ, Daniel V, Mohring K, Staehler G, Opelz G. Association of kidney graft failure with a positive flow cytometric crossmatch. Clin Transplant. 1992;6:31-34.
12. SAS/STAT User's Guide. Version 6.08. 4th Ed. Gary, NC: SAS Institute Inc; 1989.
13. Sridhar NR, Munda R, Balakrishnan K, First MR. Evaluation of flowcytometric crossmatching in renal allograft recipients, Nephron. 1992;62:262-266.
14. Ogura K, Terasaki PI, Johnson C, et al. The significance of a positive flow cytometry crossmatch test in primary kidney transplantation. Transplantation. 1993;56:294-298.